Age-related adverse effects of Tamoxifen in female breast cancer patients: Insights from the FDA's adverse event reporting system
Journal of Oncology Pharmacy Practice
Published online on May 13, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
BackgroundTamoxifen is an effective treatment for hormone receptor-positive breast cancer (BC). Despite its effectiveness, there have been many reports of adverse reaction.However, the relationship between Tamoxifen-related adverse events (ADEs) and ...
BackgroundTamoxifen is an effective treatment for hormone receptor-positive breast cancer (BC). Despite its effectiveness, there have been many reports of adverse reaction.However, the relationship between Tamoxifen-related adverse events (ADEs) and ...